- Home
- Clinical Trials
Migraine Study Sydney DH 102
Migraine Study
Darlinghurst Sydney
Are Migraine attacks disrupting your life?
We are conducting a research study to evaluate a new potential treatment for adults suffering from recurring migraine episodes. The study treatment is designed to relieve migraine pain and related symptoms like nausea and extreme sensitivity to light and sound.
Description
What to expect
Study details
Ages
18 to 65 years old
Duration
Approximately 2 months and involves 3 clinic visits
Compensation
You will be reimbursed for your time in the research study
Eligibility Criteria
This study may be suitable for you if you:
- Are aged 18 to 65 years old
- Have suffered from symptoms of migraine attacks for at least a year AND,
- Have a history of 2 to 8 migraine attacks on average per month with moderate or severe pain.
Additional study requirements will apply.
Locations
Description
A Migraine is more than simple headaches. These episodes can bring intense throbbing pain and are often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Migraine attacks can persist for hours or even days, deeply impacting your ability to carry out everyday activities and enjoy life.
While treatments are available, many individuals still struggle with managing their symptoms effectively. Current therapies, including medications designed to alleviate symptoms and prevent future episodes, don't work for everyone and can sometimes lead to significant side effects. This underscores the urgent need for innovative treatments.
This study investigates a new potential medication intended to provide relief right when symptoms start, aiming to prevent them from escalating into full-blown attacks. This could offer a promising new avenue for those seeking more effective migraine management.
What to expect
Potential participants start with a screening visit at our clinic to determine if the study is right for you. If the study is suitable, you will then be invited to attend a randomisation visit. At this visit, participants will be randomly assigned to a treatment group and receive study-related training, and a supervised test dose of the study medication.
You will then be provided with a single dose of the study medication to use at home following the onset of a migraine attack.
Throughout the study, participants will maintain a detailed electronic diary, logging any symptoms experienced and the effectiveness of the medication.
Following your migraine episode, a follow-up visit will be scheduled at our clinic. During this visit, our professional medical team will conduct further tests and assessments to monitor your progress and health.
We invite you to register your interest now to discover if this study could be a good fit for you.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.